Literature DB >> 23591474

Genetic diversity of bile salt hydrolases among human intestinal bifidobacteria.

Piotr Jarocki1, Zdzisław Targoński.   

Abstract

This study analyzes the application of degenerative primers for the screening of bile salt hydrolase-encoding genes (bsh) in various intestinal bifidobacteria. In the first stage, the design and evaluation of the universal PCR primers for amplifying the partial coding sequence of bile salt hydrolase in bifidobacteria were performed. The amplified bsh gene fragments were sequenced and the obtained sequences were compared to the bsh genes present in GenBank. The determined results showed the utility of the designed PCR primers for the amplification of partial gene encoding bile salt hydrolase in different intestinal bifidobacteria. Moreover, sequence analysis revealed that bile salt hydrolase-encoding genes may be used as valuable molecular markers for phylogenetic studies and identification of even closely related members of the genus Bifidobacterium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591474      PMCID: PMC3722454          DOI: 10.1007/s00284-013-0362-1

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


Introduction

Members of the genus Bifidobacterium are anaerobic Gram-positive Actinobacteria, which are commonly found in the gastrointestinal tract (GIT) of humans and animals [21, 22]. Numerous studies have shown that the presence of the bifidobacteria in the human gut is associated with many health-promoting effects, such as immunomodulation, prevention of diarrhea, reduction of pathogens and toxic compounds, decrease of lactose intolerance, and stabilization of the state of the intestine [2, 3, 6, 11]. Because of this, they are frequently used as food additives in the dairy industry and therapeutic agents in some probiotic pharmaceuticals. In previous research, various molecular methods were used for detection and specific identification of Bifidobacterium strains [10, 23]. Among them, a sequence analysis of 16S rDNA has been used widely for both the preparation of species-specific PCR primers and bacterial-phylogeny analysis [13, 14]. However, because some bifidobacterial species showed a high degree of similarity to this gene sequence, alternative molecular markers were tested as well as applied for rapid identification, and a phylogenetic relationship study between different members of the genus Bifidobacterium [5, 22]. It has been suggested previously that genetic analysis of bile salt hydrolases may provide important information about the phylogeny and the genetic diversity of the genus Bifidobacterium [7]. In this study, we present the application of degenerative primers for the screening of bsh genes in various human intestinal bifidobacteria. In the first stage, the design and evaluation of the universal PCR primers for amplifying the partial coding sequence of bile salt hydrolase in different species of Bifidobacterium were performed. Next, the amplified gene fragments were sequenced, and the obtained results were then compared with the bsh genes present in GenBank. Finally, the expression of bile salt hydrolase genes was tested by the RT-PCR detection of internal fragments of the analyzed bsh genes.

Materials and Methods

Bacterial Strains and Culture Conditions

This study involved twenty-two strains of bifidobacteria (Table 1). All intestinal isolates were cultured in a modified Garche’s medium [4]. BSH-negative strains (B. asteroides and B. coryneforme) which originated from the hindgut of honeybee, were grown in MRS broth (Oxoid) supplemented with cysteine HCl. The cultures were routinely incubated at 37 °C in an anaerobic jar (Oxoid) for 24 h.
Table 1

List of bacterial strains used in this study

StrainGenBank accession no.
Bifidobacterium adolescentis DSM 20083T JX880242
Bifidobacterium adolescentis DSM 20086JX880243
Bifidobacterium adolescentis DSM 20087JQ696811
Bifidobacterium angulatum DSM 20098T JX880238
Bifidobacterium animalis subps. lactis NRRL B-41405JQ696813
Bifidobacterium animalis subps. animalis NRRL B-41406T JQ696812
Bifidobacterium asteroides DSM 20089T
Bifidobacterium bifidum DSM 20456T JQ696814
Bifidobacterium breve DSM 20091JQ696815
Bifidobacterium breve NRRL B-41408T JQ696816
Bifidobacterium catenulatum DSM 20224JQ696817
Bifidobacterium coryneforme DSM 20216T
Bifidobacterium gallicum DSM 20093T JX880240
Bifidobacterium longum subps. infantis ATCC 15697T JQ696818
Bifidobacterium longum subps. longum NRRL B-41409T JQ696819
Bifidobacterium longum subps. suis NRRL B-41407T JQ696822
Bifidobacterium pseudocatenulatum DSM 20439JQ696820
Bifidobacterium pseudolongum subsp. globosum DSM 20092T JX880241
Bifidobacterium pseudolongum subsp. pseudolongum DSM 20094JX880244
Bifidobacterium pseudolongum subsp. pseudolongum DSM 20095JX880245
Bifidobacterium pseudolongum subsp. pseudolongum DSM 20099T JQ696821
Bifidobacterium ruminantium DSM 6489T JX880239
List of bacterial strains used in this study

Total DNA Extraction and Polymerase Chain Reaction

The isolation of chromosomal DNA from Bifidobacterium strains used in this study was carried out from an overnight culture, using the Total DNA Mini Kit (A&A Biotechnology, Poland). Universal primers were designed for the amplification of the partial genes encoding the bile salt hydrolase (Table 2). Each reaction mixture contained 0.25 U of Taq DNA polymerase (Fermentas), 200 μM of each deoxynucleoside triphosphate, PCR buffer (Fermentas), 1 or 2 μM of each primer, and 1 μl (10–30 ng) of bacterial DNA in the final volume of 20 μl. Amplification was performed using the LabCycler (SensoQuest, Germany) programmed as follows: 5 min at 94 °C for initial denaturation and 35 cycles of 1 min at 94 °C, an annealing step at 55–60 °C for 1 min, 1 min at 72 °C for extension and 10 min at 72 °C for a final extension. Five stool samples were collected from healthy humans and stored in −20 °C. Genomic DNA from a portion of fecal samples (about 200 mg) was isolated by using a GeneMATRIX Stool DNA Purification Kit (EURx, Poland). Six probiotic products including different kinds of liquid yogurts manufactured by five companies were collected. Next, DNA was extracted directly from 300 mg of each yogurth sample by using a GeneMATRIX Food-Extract DNA Purification Kit (EURx, Poland). Afterward, 1 and 5 μl of the resultant samples were used for PCR screening. The PCR products were analyzed by agarose gel electrophoresis with 1.4 % (w/v) agarose in a Tris–acetate-EDTA buffer (TAE). The gels were stained with ethidium bromide (0.5 μg/ml) and visualized under UV light.
Table 2

Sequences of oligonucleotide primers used in this study

PrimerNucleotide sequence (5′–3′)Use
Bif-bshA-1FATGTGCACWGSYGTYCGTTTPCR screening, sequencing
Bif-bshB-2FTTCGGCCGYAAYCTCGAYTG GAGPCR screening
Bif-bshC-1RTCGAYGACGATGCTDCGPCR screening
Bif-bshD-2RGGYTGRTTGGTVAGCACRTCPCR screening, sequencing
Bif-bshE-3FTTCGGCCGYAAYCTYGAYTGGPCR screening, RT-PCR
Bif-bshF-3RTCGAYGACGATGSTDCGPCR screening, RT-PCR
Sequences of oligonucleotide primers used in this study

DNA Sequencing and Sequence Analysis

The amplified bsh gene fragments, obtained with Bif-bshA-1F and Bif-bshD-2R primers were purified using ExoSAP-IT (USB) and were subsequently sequenced. The nucleotide sequences were determined using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) and the capillary sequencing system 3730xl DNA Analyzer (Applied Biosystems). The partial gene sequences obtained in this study and those from the databases were analyzed by Clustal [20] and BLAST [1]. The phylogenetic tree was calculated using neighbor joining method [16] with software package MEGA version 4.0 [18]. The determined nucleotide sequences have been deposited in the GenBank database (Table 1).

Isolation of Bacterial RNA and RT-PCR

For isolation of RNA from bifidobacteria, cells of overnight cultures were collected by centrifugation at 10,000×g for 5 min, and then treated with a lysozyme (MP Biomedicals) solution (5 mg/ml) prepared in a TE buffer (10 mM Tris pH 7.5, 1 mM EDTA). The total RNA was isolated with a GeneMATRIX Universal RNA Purification Kit (EURx, Poland) according to the manufacturer’s instructions, and the samples were then treated with DNase (Fermentas) at 37 °C for 30 min. DNase was inactivated by using EDTA and incubated at 65 °C for 10 min. The reverse transcription of isolated RNA samples and PCR of cDNA were performed by using a GeneAmp RNA PCR Kit (Applied Biosystems) as recommended by the manufacturer. The PCR amplification was done with internal primers for the bsh genes (Table 2) in a final volume of 20 μl (including 4 μl from the RT reaction) under standard conditions as described above.

Results and Discussion

Primer Design and PCR Amplification

Modern molecular techniques based on sequence comparisons of housekeeping genes provide very useful information on the composition and phylogeny of the normal gastrointestinal microbiota. Moreover, a multilocus sequence analysis of conserved genes allows more reliable identification of isolated strains at the genus, species and sometimes even at the strain level. In this study, we analyzed the utility of bile salt hydrolase-encoding genes as genetic markers which can be applied in the specific and sensitive evaluation of the intestinal bifidobacteria. In order to determine whether all the tested strains possess bsh gene, the degenerative primers were designed based on comparison of the bsh sequences present in GenBank. We aligned four previously described BSH coding genes from four bifidobacterial species: B. longum [19], B. bifidum [9], B. adolescentis [7], and B. animalis [8]. In addition, three bsh sequences for B. catenulatum, B. dentium, and B. pseudocatenulatum originating from whole genome sequences database, were also analyzed (Fig. 1). The performed comparison indicated four highly conserved regions of bsh genes for tested bifidobacteria. Two forward primers: Bif-bshA-1F and Bif-bshB-2F with target sites starting at position 1 and 46 (with reference to the B. bifidum ATCC 29521 bsh gene, GenBank accession number: AY604517) were selected. Two reverse primers, Bif-bshC-1R and Bif-bshD-2R, were designed based on other conserved sites starting at positions 448 and 505, respectively. All primers designed in this study were then tested in polymerase chain reactions with DNA isolated from 14 strains of bifidobacteria. The obtained results demonstrated the utility of these primers for the amplification of bsh fragments from different intestinal bifidobacterial species (Fig. 2). The amplification was less efficient for B. pseudolongum compared with the other strains. In addition, PCR with the third oligonucleotide pair (Bif-bshB-2F and Bif-bshC-1R) showed that this primer set was not suitable for amplification of the specific fragment of bsh of B. pseudolongum. In all cases, two BSH-negative reference strains (B. asteroides and B. coryneforme) were negative in the PCR screening with the above primer sets and gave only weak and unspecific bands.
Fig. 1

Alignment of partial bsh genes from various bifidobacteria and design of universal primers for PCR. Abbreviation for BSHs: B. adol B. adolescentis ATCC 15703 (AP009256.1), B. long B. longum SBT2928 (AF148138.1), B. bif B. bifidum ATCC 29521 (AY604517.1), B. cat B. catenulatum DSM 16992 (NZ_ABXY01000011.1), B. pscat B. pseudocatenulatum DSM 20438 (NZ_ABXX02000003.1), B. dent B. dentium Bd1 (CP001750.1), B. animalis subsp. lactis KL612 (AY530821.1). Asterisks indicate identical nucleotides. Four highly conserved regions of bsh genes used for primers design are underlined

Fig. 2

PCR screening of different Bifidobacterium strains with primers: Bif-bshA-1F and Bif-bshC-1R (a), Bif-bshA-1F and Bif-bshD-2R (b), Bif-bshB-2F and Bif-bshC-1R (c), and Bif-bshB-2F and Bif-bshD-2R (d). Lanes: 1 DNA molecular weight marker (in base pairs), 2 B. adolescentis DSM 20087, 3 B. animalis subps. lactis NRRL B-41405, 4 B. animalis subps. animalis NRRL B-41406, 5 B. bifidum DSM 20456, 6 B. breve DSM 20091, 7 B. breve NRRL B-41408, 8 B. catenulatum DSM 20224, 9 B. longum subsp. infantis ATCC 15697, 10 B. longum subsp. longum NRRL B-41409, 11 B. pseudocatenulatum DSM 20439, 12 B. pseudolongum DSM 20099, 13 B. longum subsp. suis NRRL B-41407, 14 B. asteroides DSM 20089, 15 B. coryneforme DSM 20216, 16 negative control

Alignment of partial bsh genes from various bifidobacteria and design of universal primers for PCR. Abbreviation for BSHs: B. adol B. adolescentis ATCC 15703 (AP009256.1), B. long B. longum SBT2928 (AF148138.1), B. bif B. bifidum ATCC 29521 (AY604517.1), B. cat B. catenulatum DSM 16992 (NZ_ABXY01000011.1), B. pscat B. pseudocatenulatum DSM 20438 (NZ_ABXX02000003.1), B. dent B. dentium Bd1 (CP001750.1), B. animalis subsp. lactis KL612 (AY530821.1). Asterisks indicate identical nucleotides. Four highly conserved regions of bsh genes used for primers design are underlined PCR screening of different Bifidobacterium strains with primers: Bif-bshA-1F and Bif-bshC-1R (a), Bif-bshA-1F and Bif-bshD-2R (b), Bif-bshB-2F and Bif-bshC-1R (c), and Bif-bshB-2F and Bif-bshD-2R (d). Lanes: 1 DNA molecular weight marker (in base pairs), 2 B. adolescentis DSM 20087, 3 B. animalis subps. lactis NRRL B-41405, 4 B. animalis subps. animalis NRRL B-41406, 5 B. bifidum DSM 20456, 6 B. breve DSM 20091, 7 B. breve NRRL B-41408, 8 B. catenulatum DSM 20224, 9 B. longum subsp. infantis ATCC 15697, 10 B. longum subsp. longum NRRL B-41409, 11 B. pseudocatenulatum DSM 20439, 12 B. pseudolongum DSM 20099, 13 B. longum subsp. suis NRRL B-41407, 14 B. asteroides DSM 20089, 15 B. coryneforme DSM 20216, 16 negative control The utility of designed primers for the detection of BSH-positive Bifidobacterium strains was also evaluated using DNA isolated from fecal samples and dairy products. As expected, the PCR screening with primers Bif-bshB-2F and Bif-bshC-1R, showed that the specific products of expected size (524 bp) were obtained for all DNA samples isolated from feces (Fig. 3a). Likewise, all assayed commercial probiotic products also gave positive results (detectable, specific bands) showing that they contain bacterial strains with bsh genes and the presumed bile salt activity (Fig. 3b). The obtained results showed that the developed primers can be useful for rapid detection of BSH-positive bifidobacteria and for the monitoring of the occurrence of BSH activity in the analyzed samples.
Fig. 3

Agarose gel electrophoresis of PCR products obtained with primers Bif-bshA-1F and Bif-bshD-2R for DNA samples extracted from feaces (a) and probiotic products (b). Lanes: a 1 DNA molecular weight marker (in base pairs), 2–6 genomic DNAs directly extracted from five stool samples, 7 negative control, b 1 DNA molecular weight marker, 2–7 genomic DNA directly extracted from six probiotic products, 8 negative control

Agarose gel electrophoresis of PCR products obtained with primers Bif-bshA-1F and Bif-bshD-2R for DNA samples extracted from feaces (a) and probiotic products (b). Lanes: a 1 DNA molecular weight marker (in base pairs), 2–6 genomic DNAs directly extracted from five stool samples, 7 negative control, b 1 DNA molecular weight marker, 2–7 genomic DNA directly extracted from six probiotic products, 8 negative control

Determination and Analysis of the Partial Coding Sequences of Bile Salt Hydrolase

Previously amplified PCR products generated with the Bif-bshA-1F and Bif-bshD-2R primers for 20 bifidobacteria were purified and sequenced. Subsequently, the obtained results were aligned with bsh genes present in GenBank. For all tested strains, the amplified DNA fragment contained a partial sequence of bsh. In the case of B. adolescentis DSM 20087, the generated bsh sequence showed a high similarity (more than 99.6 %) with strains of B. adolscentis previously described [7]. In addition, all the analyzed bsh sequences from this species share more than 99 % similarity with bsh sequence obtained for B. ruminantium. These results were similar to the recent analysis of 16S rRNA gene sequences, which indicated high relatedness of these two taxa. The obtained sequences revealed significantly lower similarity (below 89 %) with bsh genes from other species of Bifidobacterium. Likewise, different strains of B. animalis subsp. lactis were also observed to possess identical bsh gene sequences and to share at most 72 % similarity with respect to all of the other members of the analyzed genus. Interestingly, partial bsh sequence of B. animalis subsp. animalis revealed 98.7 % identity with a respective sequence from B. animalis subsp. lactis. This result confirmed previous findings which indicated that these two taxa should be distinguished and considered as two separate subspecies in B. animalis [12]. Comparison of the obtained bsh sequence for type strain of B. bifidum with other sequences present in GenBank revealed that among the strains of the species B. bifidum, the BSH DNA sequence similarities ranged from 97.3 to 99.6 %. In addition, the type strain used in this study revealed a high degree of similarity with B. catenulatum DSM 20224 (95 %) and B. pseudocatenulatum DSM 20439 (92 %). The partial sequence of bsh for B. bifidum DSM 20456 exhibited the highest sequence similarity with B. bifidum S17 (99.6 %) and B. bifidum ATCC 15696 (99.4 %), and lower similarity (<99 %) with other analyzed strains from B. bifidum species. It is also noteworthy that 16S rDNA sequence similarities of all B. bifidum strains present in NCBI database were above 99 %. These results suggest that in some cases bsh may be a useful genetic marker for specific identification of analyzed bacteria even at the strain level. However, for more detailed evaluation of the utility of bile salt hydrolase-encoding gene for intraspecies differentiation of bifidobacteria further thorough studies involving a larger number of bacterial strains are necessary. Highly conserved bsh sequences were characteristic for B. breve strains. Two analyzed members of this species had identical sequences for the partial bsh gene. Analysis of bsh sequences revealed a high degree of relatedness between B. breve strains and bifidobacteria from B. longum group, i.e., B. longum subsp. longum (99. 3 %), B. longum subsp. suis (98.5 %), and B. longum subsp. infantis (97.5 %). In contrast, B. breve was found to share a significantly lower similarity (below 87 %) with other analyzed species from the genus of Bifidobacterium. These results are in good agreement with the observations made by Ventura et al. [22] presenting B. breve as a closely related species with other bifidobacteria belonging to B. longum group. The taxonomic position of B. longum subsp. longum, B. longum subsp. infantis, and B. longum subsp. suis was intensively explored in previous articles [14, 17]. The results obtained in this study also showed the very close phylogenetic relationship among these three taxa. However, clear differences were also evident. For B. longum subsp. infantis and B. longum subsp. suis used in our study, the partial sequences of bsh were found to share 97.7 and 98.7 % similarities, respectively, with bsh from type strain of B. longum subsp. longum. These results support the previous proposal to classify B. longum subsp. longum, B. longum subsp. infantis, and B. longum subsp. suis as three subspecies of B. longum. The previous study revealed an extremely high 16S rDNA sequence similarity (99.5 %) between B. catenulatum and B. pseudocatenulatum [15]. Interestingly, our analysis of partial BSH gene sequences showed that bsh of B.catenulatum DSM 20224 was found to share only 93 % similarity with the sequence determined for B. pseudocatenulatum DSM 20439. The obtained results indicate the interspecies relationship between these two taxa and are consistent with the previous conclusion [24]. Our study also showed the utility of bsh for the genetic identification of B. angulatum, B. gallicum, and B. pseudolongum. The determined partial bsh sequences for these species revealed very low similarity with bsh from other bifidobacteria (below 73, 68, and 72 %, respectively). Moreover, the BSH DNA sequence similarity between the two subspecies of B. pseudolongum (B. pseudolongum subsp. pseudolongum and B. pseudolongum subsp. globosum) was only 90 %. In general, the clustering tree for bsh sequences was similar to phylogenetic analysis based on 16S rRNA gene sequences obtained for bifidobacterial taxa used in this study (Fig. 4). However, clear differences were also evident. For the partial bsh sequence, the similarity among bifidobacterial species analyzed in this study ranged from 63.2 to 99.6 %. In comparison, 16S rRNA sequence similarity for Bifidobacterium species varied from 90.2 to 99.9 % [5]. Interestingly, very high similarities (above 99 %) were determined among bifidobacteria from B. longum group (B. longum and B. breve) and also for two species belonging to B. adolescentis group (B. adolescentis and B. ruminantium). These results are in good agreement with previous phylogenetic analysis of the genus Bifidobacterium using 16S rRNA sequences performed by Ventura et al. [22]. Further phylogenetic analysis should clarify the taxonomic position of these close-related taxa, i.e., the classification at subspecies level. The partial bsh gene sequences showed intraspecies variation up to 3 %; however, for two subspecies of B. pseudolongum, sequence difference reached more than 10 %. These results demonstrate that in some cases bsh sequences possess a definitely higher discriminatory power than the previously described genetic markers [5, 15, 22].
Fig. 4

Phylogenetic trees based on partial sequences of bsh for bifidobacteria used in this study. Tree was constructed using the neighbor joining method from 1000 bootstrapping replicates

Phylogenetic trees based on partial sequences of bsh for bifidobacteria used in this study. Tree was constructed using the neighbor joining method from 1000 bootstrapping replicates Based on the previously determined bsh sequences, internal primers were improved (Bif-bshE-3F 5′-TTCGGCCGYAAYCTYGAYTGG-3′ and Bif-bshF-3R 5′-TCGAYGACGATGSTDCG-3′) and then used for PCR screening and RT-PCR detection of transcription of bsh genes. As expected, the expression of bsh for all the analyzed bifidobacteria was confirmed by electrophoretic detection of an ~415-bp internal fragment of bsh.

Conclusions

In summary, this study describes the use of bsh gene for the specific identification of human intestinal bifidobacteria. The phylogenetic analysis of the determined sequences revealed that the bsh genes showed significantly higher genetic variation than the bifidobacterial 16S rRNA sequences. Therefore, we conclude that bile salt hydrolase-encoding gene is a useful molecular marker for phylogenetic studies and specific identification of human fecal Bifidobacterium species.
  23 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

Review 2.  Getting better with bifidobacteria.

Authors:  S C Leahy; D G Higgins; G F Fitzgerald; D van Sinderen
Journal:  J Appl Microbiol       Date:  2005       Impact factor: 3.772

3.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Authors:  Koichiro Tamura; Joel Dudley; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2007-05-07       Impact factor: 16.240

4.  Phylogenetic analysis of the genus Bifidobacterium and related genera based on 16S rDNA sequences.

Authors:  T Miyake; K Watanabe; T Watanabe; H Oyaizu
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

5.  Cloning and characterization of a bile salt hydrolase (bsh) from Bifidobacterium adolescentis.

Authors:  Geun-Bae Kim; Mathieu Brochet; Byong H Lee
Journal:  Biotechnol Lett       Date:  2005-06       Impact factor: 2.461

6.  Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers.

Authors:  T Matsuki; K Watanabe; R Tanaka; M Fukuda; H Oyaizu
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

7.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

8.  Analysis of bifidobacterial evolution using a multilocus approach.

Authors:  Marco Ventura; Carlos Canchaya; Antonio Del Casale; Franco Dellaglio; Erasmo Neviani; Gerald F Fitzgerald; Douwe van Sinderen
Journal:  Int J Syst Evol Microbiol       Date:  2006-12       Impact factor: 2.747

9.  RAPD and rep-PCR fingerprinting for characterization of Bifidobacterium species.

Authors:  J Krízová; A Spanová; B Rittich
Journal:  Folia Microbiol (Praha)       Date:  2008-05-25       Impact factor: 2.099

10.  Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov.

Authors:  P Mattarelli; C Bonaparte; B Pot; B Biavati
Journal:  Int J Syst Evol Microbiol       Date:  2008-04       Impact factor: 2.747

View more
  17 in total

1.  Determination of Bile Salt Hydrolase Activity in Bifidobacteria.

Authors:  Lorena Ruiz; Borja Sánchez; Abelardo Margolles
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Consequences of bile salt biotransformations by intestinal bacteria.

Authors:  Jason M Ridlon; Spencer C Harris; Shiva Bhowmik; Dae-Joong Kang; Phillip B Hylemon
Journal:  Gut Microbes       Date:  2016

3.  Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota.

Authors:  Sandra Martín-Peláez; Juana Ines Mosele; Neus Pizarro; Marta Farràs; Rafael de la Torre; Isaac Subirana; Francisco José Pérez-Cano; Olga Castañer; Rosa Solà; Sara Fernandez-Castillejo; Saray Heredia; Magí Farré; María José Motilva; Montserrat Fitó
Journal:  Eur J Nutr       Date:  2015-11-05       Impact factor: 5.614

4.  Genome-Wide Assessment of Stress-Associated Genes in Bifidobacteria.

Authors:  Marie Schöpping; Tammi Vesth; Kristian Jensen; Carl Johan Franzén; Ahmad A Zeidan
Journal:  Appl Environ Microbiol       Date:  2022-03-21       Impact factor: 4.792

5.  A new insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium.

Authors:  Piotr Jarocki; Marcin Podleśny; Paweł Glibowski; Zdzisław Targoński
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

6.  Abundance profiling of specific gene groups using precomputed gut metagenomes yields novel biological hypotheses.

Authors:  Konstantin Yarygin; Alexander Tyakht; Andrey Larin; Elena Kostryukova; Sergei Kolchenko; Vilgelm Bitner; Dmitry Alexeev
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Intra-species Genomic and Physiological Variability Impact Stress Resistance in Strains of Probiotic Potential.

Authors:  Jason W Arnold; Joshua B Simpson; Jeffrey Roach; Jakub Kwintkiewicz; M Andrea Azcarate-Peril
Journal:  Front Microbiol       Date:  2018-02-20       Impact factor: 5.640

Review 8.  Modulation of the Gut Microbiota by Olive Oil Phenolic Compounds: Implications for Lipid Metabolism, Immune System, and Obesity.

Authors:  Marta Farràs; Laura Martinez-Gili; Kevin Portune; Sara Arranz; Gary Frost; Mireia Tondo; Francisco Blanco-Vaca
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

9.  Integrative Analysis of Colonic Biopsies from Inflammatory Bowel Disease Patients Identifies an Interaction Between Microbial Bile Acid-inducible Gene Abundance and Human Angiopoietin-like 4 Gene Expression.

Authors:  Cristian Hernández-Rocha; Krzysztof Borowski; Williams Turpin; Melissa Filice; Shadi Nayeri; Juan Antonio Raygoza Garay; Joanne M Stempak; Mark S Silverberg
Journal:  J Crohns Colitis       Date:  2021-12-18       Impact factor: 10.020

10.  Comparison of various molecular methods for rapid differentiation of intestinal bifidobacteria at the species, subspecies and strain level.

Authors:  Piotr Jarocki; Marcin Podleśny; Elwira Komoń-Janczara; Jagoda Kucharska; Agnieszka Glibowska; Zdzisław Targoński
Journal:  BMC Microbiol       Date:  2016-07-22       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.